FilingSEC EDGAR8-K
Tempest Therapeutics Appoints John Frederick as Independent Director
· SEC accepted
StageDirector Appointment
Filing content
Tempest Therapeutics announced the appointment of John Frederick to its board of directors, effective October 13, 2026.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…